IL6 and colitis: The mRNA expression levels of pro-inflammatory cytokines, including IL-1B, IL-17, and IL-6, were significantly downregulated in the 3D-TMSC-treated group when compared with those in the colitis control group (P = 0.001, P = 0.001, and P = 0.024, respectively, Fig. 6).